Hypogonadism

• 

  Subject Areas on Research

  • A study of pituitary function in patients with idiopathic hemochromatosis. 
  • Choanal atresia and associated anomalies. 
  • Effects of long-term estrogen replacement therapy. I. Metabolic effects. 
  • Effects of long-term testosterone treatment on cardiovascular outcomes in men with hypogonadism: Rationale and design of the TRAVERSE study. 
  • Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men. 
  • Familial variable expression of dilated cardiomyopathy in Alström syndrome: a report of four sibs. 
  • Hypothalamic and pituitary function in hypogonadotropic hypogonadism. 
  • Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. 
  • Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. 
  • Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation. 
  • Markers of Iron Flux during Testosterone-Mediated Erythropoiesis in Older Men with Unexplained or Iron-Deficiency Anemia. 
  • Microcephaly, hypergonadotropic hypogonadism, short stature, and minor anomalies: a new syndrome. 
  • Mutations in CUL4B, which encodes a ubiquitin E3 ligase subunit, cause an X-linked mental retardation syndrome associated with aggressive outbursts, seizures, relative macrocephaly, central obesity, hypogonadism, pes cavus, and tremor. 
  • New testosterone buccal system (Striant) delivers physiological testosterone levels: pharmacokinetics study in hypogonadal men. 
  • Prader Willi Syndrome: Genetics, Metabolomics, Hormonal Function, and New Approaches to Therapy. 
  • Predicting low testosterone in aging men: a systematic review. 
  • Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts. 
  • Secondary osteoporosis. Diagnostic considerations. 
  • Stimulation of spermatogenesis with recombinant human follicle-stimulating hormone (follitropin alfa; GONAL-f): long-term treatment in azoospermic men with hypogonadotropic hypogonadism. 
  • Testosterone Therapy on Active Surveillance and Following Definitive Treatment for Prostate Cancer. 
  • Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. 
  • Visual vignette. Empty sella syndrome with central hypothyroidism and hypogonadism.